Copyright
©The Author(s) 2023.
World J Gastroenterol. Oct 7, 2023; 29(37): 5313-5326
Published online Oct 7, 2023. doi: 10.3748/wjg.v29.i37.5313
Published online Oct 7, 2023. doi: 10.3748/wjg.v29.i37.5313
Figure 3 Association between leukocyte immunoglobulin-like receptor B2 and angiopoietin-like protein 2 expression and the prognosis of colorectal cancer.
A: Angiopoietin-like protein 2 (ANGPTL2) mRNA expression and overall survival of colorectal cancer (CRC); B: ANGPTL2 mRNA expression and progression-free survival of CRC; C: Leukocyte immunoglobulin-like receptor B2 (LILRB2) mRNA expression and overall survival of CRC; D: LILRB2 protein expression and overall survival of CRC. LILRB2: Leukocyte immunoglobulin-like receptor B2; ANGPTL2: Angiopoietin-like protein 2; CRC: Colorectal cancer.
- Citation: Wang QQ, Zhou L, Qin G, Tan C, Zhou YC, Yao SK. Leukocyte immunoglobulin-like receptor B2 overexpression as a promising therapeutic target and noninvasive screening biomarker for colorectal cancer. World J Gastroenterol 2023; 29(37): 5313-5326
- URL: https://www.wjgnet.com/1007-9327/full/v29/i37/5313.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i37.5313